Ligand validation:5RCE

RE4: 6-methyl-N~4~-[(pyridin-3-yl)methyl]pyrimidine-2,4-diamine

RE4 is a Ligand Of Interest in 5RCE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5RCE_RE4_A_401	55%	89%	0.126	0.894	0.27	0.37	-	-	1	0	100%	0.29
5RCE_RE4_A_403	36%	71%	0.13	0.823	0.47	0.64	-	-	0	0	100%	0.29
5RCE_RE4_A_402	33%	83%	0.163	0.843	0.31	0.46	-	-	0	0	100%	0.29
5R2C_RE4_A_402	20%	83%	0.174	0.772	0.41	0.38	-	-	0	0	100%	0.68
8CFW_RE4_B_506	13%	10%	0.173	0.713	2.29	2.04	2	6	1	0	100%	0.74

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.